Data analytics company Arcadia raises $125M and more digital health fundings

Information analytics firm Arcadia secures $125 million from strategic investor and financing associate Vista Credit score Companions, Vista Fairness Companions’ credit-lending arm. 

The funds will probably be used to hurry up the corporate’s platform growth and speed up its go-to-market technique. 

“Vista Credit score Companions is the popular associate to assist us obtain our targets, offering new financing and entry to the broader Vista ecosystem, which holds deep experience and assets for scaling well being tech and enterprise software program companies. We look ahead to additional investing in our platform, our service supply and buyer relations to solidify our place because the main information platform for healthcare organizations,”  Michael Meucci, CEO of Arcadia, stated in an announcement. 

Spring Health, which provides digital psychological healthcare and navigation companies, introduced it had raised $71 million, boosting its valuation to $2.5 billion.

In a weblog put up, the startup stated the newest elevate would give it flexibility to spend money on companies “alongside our path to profitability.”

Spring final raised $190 million in Series C funding in 2021. Final 12 months, it acquired Weldon, which supplied psychological wellness steering to oldsters via chats with therapists, social staff and parenting coaches in addition to group assist and academic content material.

Well being information aggregation and centralization platform 1upHealth closed a $40 million Sequence C funding spherical. 

Sixth Avenue Development led the spherical with participation from current buyers Jackson Sq. Ventures, F-Prime Capital and Eniac Ventures. Lee Mooney, managing director at Sixth Avenue Development, will be a part of 1upHealth’s board of administrators.

The Boston-based firm provides a cloud-based, AI-enabled, FHIR-native platform that permits sufferers, builders and suppliers to mixture and share well being information, together with data from EHRs. 1upHealth will use the funds to additional develop its Information Cloud product and develop its workforce. 

“With proposed federal laws requiring enhanced well being data alternate capabilities, 1upHealth is well-positioned to reply to these market forces whereas serving to healthcare organizations improve the utility of their information utilizing fashionable database know-how,” Mooney stated in an announcement.

Treatment adherence firm Scene Well being (previously emocha) raised $17.7 million in a Sequence B financing spherical, bringing its complete elevate to over $25 million.

ABS Capital Companions led the spherical with participation from current buyers Claritas Well being Ventures, Healthworx, Kapor Capital and PTX Capital. 

Cal Wheaton, common associate of ABS Capital Companions, will be a part of Scene’s board of administrators. 

Scene Well being provides Immediately Noticed Remedy by way of asynchronous, livestream and in-person appointments, the place nurses, pharmacists and well being coaches can watch how sufferers take their remedy, comparable to an inhaler, to make sure correct use. Sufferers are additionally provided remedy reminders by way of the app, which incorporates monetary incentives and academic video content material. 

The corporate will use the cash to speed up its capability to work with Medicaid managed care and Medicare Benefit plans, scientific analysis organizations and pharmaceutical corporations. 

“We’re thrilled to be partnering with Scene and its skilled workforce to increase the scope of Scene’s constructive affected person engagement and influence whereas meaningfully decreasing the monetary burden related to remedy nonadherence for Scene’s different clients,” Wheaton stated in an announcement. 

Final week, the corporate acquired a $1.67 million grant from the National Institutes of Health to offer its remedy adherence choices to pediatric coronary heart transplant recipients in Florida. 

Ty Vachon will provide extra element within the HIMSS23 session “ML and AI Discussion board: 2023 AI in Healthcare: The Good, The Unhealthy and The Hopeful.” It’s scheduled for Monday, April 17 at 3 p.m. – 4 p.m. CT on the South Constructing, Degree 1, room S100 B.